Tokushima, Japan

Hiroshi Akagi

This inventor holds 3 USPTO granted patents. Top assignees: Otsuka Kagaku Kabushiki Kaisha, Taiho Pharmaceutical Company Limited. Active years: 1990-1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hiroshi Akagi. Retrieved from https://idiyas.com/inventor/hiroshi-akagi-xqpsp0rv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.9

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 1990-1997

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Hiroshi Akagi: Innovator in Cephem Compounds

Introduction

Hiroshi Akagi is a notable inventor hailing from Tokushima, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his work with cephem compounds. With a total of three patents to his name, Akagi's innovations have had a marked impact on antimicrobial treatments.

Latest Patents

Among Hiroshi Akagi's most recent patents are the cephem compound itself and the process for producing this compound. Additionally, he has patented an antimicrobial cephem compound and a pharmaceutical composition containing this compound. These inventions showcase his commitment to advancing healthcare solutions.

Career Highlights

Throughout his career, Hiroshi Akagi has worked with prominent companies such as Otsuka Chemical Co., Ltd. and Taiho Pharmaceutical Company Limited. His role in these organizations has allowed him to develop and refine his inventions, leading to groundbreaking advancements in the pharmaceutical sector.

Collaborations

Hiroshi Akagi has collaborated with esteemed colleagues, including Masaru Yasui and Hideaki Hanaki. These partnerships have enhanced his research and contributed to the successful development of his patented compounds.

Conclusion

Hiroshi Akagi exemplifies the spirit of innovation in the pharmaceutical industry. His work on cephem compounds and antimicrobial treatments reflects his dedication to improving health outcomes. With continued collaboration and research, Akagi is poised to influence the future of medicinal compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…